4//SEC Filing
ARIAD PHARMACEUTICALS INC 4
Accession 0001127602-13-023055
CIK 0000884731operating
Filed
Jul 16, 8:00 PM ET
Accepted
Jul 17, 5:22 PM ET
Size
8.8 KB
Accession
0001127602-13-023055
Insider Transaction Report
Form 4
Keane Raymond T
SVP General Counsel & CCO
Transactions
- Exercise/Conversion
Performance stock unit
2013-07-15−16,000→ 16,000 total→ Common Stock (16,000 underlying) - Exercise/Conversion
Common Stock
2013-07-15+16,000→ 70,096 total - Award
Performance stock unit
2013-07-15+32,000→ 32,000 total→ Common Stock (32,000 underlying)
Footnotes (3)
- [F1]Shares were acquired upon vesting of performance stock units awarded on March 20, 2012.
- [F2]Each performance stock unit represents a right to receive one share of ARIAD common stock.
- [F3]The performance stock units vest as to 50% of the award on 7/15/2013 and as to 25% on each of 7/15/2014, and 7/15/2015.
Documents
Issuer
ARIAD PHARMACEUTICALS INC
CIK 0000884731
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000884731
Filing Metadata
- Form type
- 4
- Filed
- Jul 16, 8:00 PM ET
- Accepted
- Jul 17, 5:22 PM ET
- Size
- 8.8 KB